Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Cycling: This year’s Vuelta to be decided in the mountains

Published 01/13/2018, 10:44 AM
Updated 01/13/2018, 10:50 AM
© Reuters. Trek-Segafredo rider Contador of Spain rides during the last stage of the La Vuelta Tour of Spain cycling race in Madrid

MADRID (Reuters) - Tour of Spain organizers are hoping the 2018 race will be decided in the mountains as they unveiled the course for the next edition on Saturday.

The three-week Vuelta, which will start from Malaga on Aug. 25, will feature nine summit finishes and less than 40km of time trialing.

The riders will start with an eight km prologue in Malaga and the other solo effort against the clock will be over 30.7 km in Torrelavega at the beginning of the third week.

“We want the mountains to be key again to decide the Vuelta,” said race director Javier Guillen.

Briton Chris Froome, last year’s winner, will not defend his title. He was the first British rider to win the Vuelta and the first man to claim a Tour de France/Vuelta double in the same season since the Spanish race was moved to after the Tour.

However, Froome had previously announced that he would attempt the Giro d'Italia/Tour double this year, meaning it would be too demanding to race the Vuelta after two grand tours.

The Briton could be stripped of his Vuelta title if he cannot provide a satisfactory explanation of why a urine test he gave after Stage 18 on Sept. 7 showed excessive levels of an asthma medication called Salbutamol. [nL3N1OD2VD]

The 32-year-old Froome, who rides for Team Sky, said he had done nothing wrong and would provide "whatever information" world cycling's governing UCI requires.

© Reuters. Trek-Segafredo rider Contador of Spain rides during the last stage of the La Vuelta Tour of Spain cycling race in Madrid

Salbutamol is permitted as a legal asthma drug by the World Anti-Doping Agency, and the UCI said Froome's failed urine test did not necessitate a mandatory provisional suspension.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.